11/01/2024
3:38 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:33 PM | Regeneron Pharmaceuticals (Filer)
| Form S-3ASR | |
10/31/2024
6:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
6:10 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
6:00 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:01 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/05/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:27 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:35 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
4:55 PM | POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
10:45 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:53 PM | Regeneron Pharmaceuticals (Subject)
STAHL NEIL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:33 PM | Pitofsky Jason (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:40 PM | Pitofsky Jason (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
9:43 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:18 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:06 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:15 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
6:00 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:24 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
3:39 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:41 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
1:46 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:04 PM | Regeneron Pharmaceuticals (Subject)
SCHLEIFER LEONARD S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
1:24 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:36 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
3:29 PM | BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
4:57 PM | Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
5:10 PM | Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:16 PM | Regeneron Pharmaceuticals (Subject)
YANCOPOULOS GEORGE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
3:21 PM | Regeneron Pharmaceuticals (Subject)
SCHLEIFER LEONARD S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
6:13 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
6:13 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
6:06 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
4:33 PM | Regeneron Pharmaceuticals (Subject)
RYAN ARTHUR F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
4:04 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
3:00 PM | Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:03 PM | Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Financial Prophecy (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
03/14/2024
3:31 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:04 PM | Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:04 PM | Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:04 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:34 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
2:25 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:15 PM | Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:12 PM | Regeneron Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/09/2024
5:19 PM | Capital World Investors (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
11:22 AM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024
4:59 PM | Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:07 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
4:06 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
3:05 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/02/2024
6:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:47 PM | Regeneron Pharmaceuticals (Subject)
RYAN ARTHUR F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
3:52 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
4:02 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/25/2024
10:10 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
10:11 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/23/2024
3:17 PM | GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
5:30 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:19 PM | Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:19 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:20 PM | Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:22 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Regeneron Pharmaceuticals (Issuer)
Thompson Craig B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:16 PM | Guarini Kathryn (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:17 PM | Regeneron Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:17 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:06 PM | BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:08 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:10 PM | POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
10:31 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:28 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:11 PM | Regeneron Pharmaceuticals (Subject)
YANCOPOULOS GEORGE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
3:22 PM | BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:08 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
3:22 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:10 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:11 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
10:41 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
3:02 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:02 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:02 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
